Sxt1, Isolated from a Therapeutic Phage Cocktail, Is a Broader Host Range Relative of the Phage T3
Using <i>Escherichia coli</i> BW25113 as a host, we isolated a novel lytic phage from the commercial poly-specific therapeutic phage cocktail Sextaphage<sup>®</sup> (Microgen, Russia). We provide genetic and phenotypic characterization of the phage and describe its host range...
Saved in:
| Main Authors: | Polina Iarema, Oksana Kotovskaya, Mikhail Skutel, Alena Drobiazko, Andrei Moiseenko, Olga Sokolova, Alina Samitova, Dmitriy Korostin, Konstantin Severinov, Artem Isaev |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/16/12/1905 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phage DisCo: targeted discovery of bacteriophages by co-culture
by: Eleanor A. Rand, et al.
Published: (2025-06-01) -
Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections
by: Marco Palma, et al.
Published: (2024-11-01) -
Targeted dual-receptor phage cocktail against Cronobacter sakazakii: insights into phage-host interactions and resistance mechanisms
by: Seongok Kim, et al.
Published: (2024-12-01) -
Phage Therapy as an Alternative to Antibiotics: Harnessing Phages in Oral Medicine
by: Pospiszyl Filip, et al.
Published: (2025-07-01) -
The Current Landscape of Phage–Antibiotic Synergistic (PAS) Interactions
by: Brittany S. I. Supina, et al.
Published: (2025-05-01)